V109L (p.Val109Leu) variant of CALM3 (Calmodulin-3)
V109L (p.Val109Leu) in CALM3 (Calmodulin-3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.70 / 1. The record also includes population frequency data and structural context.
V109L (p.Val109Leu) variant details
- p.Val109Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.705
- REVEL 0.71
- MetaLR 0.57
- MetaSVM 0.30
- CADD 24.70
- PolyPhen-2 0.21
- SIFT 0.82
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 9e-07)
- Structural context available